黄金城集团

<tr id='xo4lk'><strong id='xo4lk'></strong><small id='xo4lk'></small><button id='xo4lk'></button><li id='xo4lk'><noscript id='xo4lk'><big id='xo4lk'></big><dt id='xo4lk'></dt></noscript></li></tr><ol id='xo4lk'><option id='xo4lk'><table id='xo4lk'><blockquote id='xo4lk'><tbody id='xo4lk'></tbody></blockquote></table></option></ol><u id='xo4lk'></u><kbd id='xo4lk'><kbd id='xo4lk'></kbd></kbd>

<code id='xo4lk'><strong id='xo4lk'></strong></code>

<fieldset id='xo4lk'></fieldset>

<span id='xo4lk'></span>

<ins id='xo4lk'></ins>

<acronym id='xo4lk'><em id='xo4lk'></em><td id='xo4lk'><div id='xo4lk'></div></td></acronym><address id='xo4lk'><big id='xo4lk'><big id='xo4lk'></big><legend id='xo4lk'></legend></big></address>

<i id='xo4lk'><div id='xo4lk'><ins id='xo4lk'></ins></div></i>

<i id='xo4lk'></i>

Investor Relation

Contract Manufacturing

Investor Relation

Investor Relation

PERIODIC REPORT INTERIM REPORT

Overseas regulatory announcement-Announcement on Obtaining Approval Notice for Supplementary Drug Application and Other Relevant Information

Overseas Regulatory Announcement-Announcement on Esomeprazole Magnesium Having Obtained the Notification of Approval of Marketing Application for Chemical Substance Drugs

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2024

Overseas Regulatory Announcement-Announcement on the Progress of Clinical Trial of OAB-14 Dry Suspension

Interim Dividend For the Six Months Ended 30 June 2024

Payment of 2024 Interim Dividend

Announcement Notice of Board Meeting

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2024

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2024

Articles of Association

<1 2 3 4 5 6 7 ...>